From Timeshares to Peptides: How Florida Became the Proving Ground for Federal Fraud Enforcement

Every few years, prosecutors in Florida take an entire industry apart. The product changes. The structure of the case almost never does. A market opens, money moves faster than the rules, operators build businesses that look ordinary from the inside, and a task force eventually names the sector and starts indicting. If your industry fits that today, you are not the first, and the playbook being built against you is twenty years old.

Key takeaways: Florida has been a center of federal fraud enforcement for two decades, from Orlando timeshare boiler rooms to Miami healthcare schemes to today's peptide and med spa cases. The same statutes recur in every wave: mail and wire fraud under 18 U.S.C. sections 1341 and 1343, the Anti-Kickback Statute, and health care fraud under 18 U.S.C. section 1347. Florida's Patient Brokering Act (Fla. Stat. section 817.505) drove well over a hundred sober home cases after 2016. By the time an operation is named, the investigation is already months or years old and the people who signed, billed, or sold are targets. The Southern and Middle Districts of Florida produce more of these cases than almost anywhere in the country.

By the time an operation has a name and a press conference, the investigation is months or years old.

The Pattern That Repeats Every Few Years

The mechanics stay consistent. A new way to make money appears: a consumer market like timeshares, a financial product like leveraged precious metals, an insurance opening like addiction treatment, or a reimbursement stream like Medicare durable medical equipment. Early operators are aggressive but rarely think of themselves as criminals, and "everyone in the industry does it this way" becomes the operating assumption. Then enforcement catches up. The FTC, the CFTC, HHS-OIG, the FBI, FMCSA, the FDA, or a state task force studies the sector, identifies the highest-volume operators, and files. Once the first cases land, cooperators produce more targets, and the wave moves down the chain to the marketers, the professionals who signed, the labs that billed, and the salespeople who closed. The line between a hard-charging business and a federal crime is usually drawn after the fact, by a prosecutor, using a statute broad enough to reach what the industry treated as normal.

Three waves. Three industries. The same statutes appear in every charging document.

Wave One: The Telemarketing Boiler Rooms

Florida's first modern fraud economy ran on the telephone. Orlando is the timeshare capital of the country, and where the timeshares were, the resale operations followed. Boiler rooms charged owners advance fees to sell or rent units to buyers who did not exist. The FTC and the Florida Attorney General brought wave after wave of cases through the Middle and Southern Districts of Florida, banning operators and freezing assets. Then a second layer formed on top: the same victims got a second call promising to recover the money they had lost, for another up-front fee, sometimes citing the government's own enforcement actions to sound legitimate.

The model was portable. Telemarketers sold advertising in publications that barely existed, including police and firefighter magazines, charity yearbooks, and golf tournament journals, billing small businesses for ads they never agreed to. The FTC ran national sweeps against this conduct under names like Operation False Charity. The same phone rooms sold leveraged gold and silver to retirees out of Deerfield Beach, Delray Beach, and Boca Raton, charging huge undisclosed commissions on metal the customer never controlled, until the CFTC and the FTC, working with the Southern District of Florida, dismantled them. Moving companies ran a physical version of the play, holding a family's belongings hostage on a truck until the customer paid far beyond the estimate, until FMCSA's Moving Fraud Task Force shut Florida carriers down and referred criminal conduct to the Department of Justice.

Wave Two: When the Money Moved to Healthcare

The next migration was toward insurance and Medicare, where the dollars were larger. In Palm Beach County, the opioid crisis created a treatment economy overnight. Operators ran sober homes and clinics that billed insurers for treatment that was minimal or fictional, then traded patients between facilities for cash. Prosecutors called it the Florida shuffle. In 2016, State Attorney Dave Aronberg created the Palm Beach County Sober Homes Task Force, and Florida's Patient Brokering Act became the charging tool in well over a hundred arrests. Toxicology labs were central. Urine testing was so profitable that operators called it liquid gold, and lab owners paid kickbacks for samples.

Federal enforcement scaled the same logic nationwide, with Florida at the center. In April 2019, the Department of Justice announced Operation Brace Yourself, a $1.2 billion takedown built on telemedicine doctors who signed orders for orthotic braces without examining the patients, durable medical equipment companies that billed Medicare, and call centers that paid the kickbacks. Months later came Operation Double Helix, a $2.1 billion genetic testing case, where cancer-risk and cardiac genetic screens were ordered for seniors recruited at health fairs and signed up by telemarketers. By 2020, a single telemedicine takedown pushed past $4.5 billion in charged claims. The cycle has not slowed. By the 2025 National Health Care Fraud Takedown, the numbers had reached $14.6 billion in intended loss and 324 defendants across 50 districts, with telemedicine and genetic testing again leading and a South Florida durable medical equipment scheme among the highlighted cases.

The current wave follows the same pattern: money moving faster than the rules, operators who do not think of themselves as criminals, and federal enforcement that arrives after the industry has already normalized the conduct.

Wave Three: Peptides and Med Spas

The current frontier is wellness. Peptides, compounded weight-loss drugs, hormone therapies, and the med spas and online vendors selling them sit in a regulatory gray zone. It is the same setup: money flowing, rules unsettled, aggressive marketing and creative sourcing treated as normal. The FDA is already moving, building cases under the Drug Supply Chain Security Act using manufacturer and distributor purchase records, issuing warning letters, and referring misbranding and unapproved-drug conduct for criminal prosecution. Marketing claims that outrun the science are turning into wire fraud theories. The med spa owner who buys product through an unauthorized channel, or the vendor whose website implies human use of a research compound, is standing exactly where the brace supplier and the genetic lab stood in 2019.

The Statutes Behind Every Wave

Strip away the industry and the same federal tools appear in case after case:

18 U.S.C. section 1341 and 18 U.S.C. section 1343, mail and wire fraud, the workhorses of every telemarketing, timeshare, and marketing-claim case, up to 20 years per count.

18 U.S.C. section 1347, health care fraud, and the Anti-Kickback Statute at 42 U.S.C. section 1320a-7b, which drive the DME, lab, genetic testing, and sober home cases.

18 U.S.C. section 1349, conspiracy, which reaches everyone connected to the structure on a single theory.

18 U.S.C. section 1956, money laundering, once the proceeds move through shell accounts.

21 U.S.C. sections 331 and 333, the Food, Drug, and Cosmetic Act provisions now driving peptide and med spa enforcement.

31 U.S.C. section 3729, the civil False Claims Act, which runs in parallel and can be worse than the criminal case.

Fla. Stat. section 817.505, Florida's Patient Brokering Act, the state charge that powered the sober home cases.

Different products, same architecture. Once you can read the statutes, you can see the next wave coming.

Different products, same architecture. Once you can read the statutes, you can see the next wave coming.

What This History Tells You If You Are in the Next Wave

The most important fact in any of these cases is the timeline. By the time an operation has a name and a press conference, the investigation is months or years old. Subpoenas have gone out, cooperators have been signed, the data has been pulled. The people who come through intact are rarely the ones who waited for an indictment. They saw early that their entire sector was a target and acted on it.

The mistakes are consistent across twenty years. Talking to FBI, FDA, or OIG agents without counsel because cooperation looks innocent. Producing documents in response to a subpoena or civil investigative demand without a strategy. Assuming that because the business is still running and no one has been charged, the risk is only theoretical, when widespread industry conduct is closer to a map for the prosecution than a defense.

A federal target letter or a CID from HHS-OIG is not the start of the problem. It is the middle of it. If you operate in peptides, med spas, telehealth, diagnostics, or any sector where the money is moving faster than the regulators, the time to get a federal criminal defense attorney involved is before the agent calls, not after. Early intervention is where these cases are won.

Common Questions

Facing a Federal Investigation in Florida?

AMC Defense Law represents business owners, executives, licensed professionals, and entrepreneurs in federal and state investigations across the Southern and Middle Districts of Florida and nationwide, in healthcare fraud, wire fraud, telemarketing, and FDA enforcement matters. If you are operating in a sector drawing federal attention, or you have received a subpoena, a target letter, or a knock on the door, contact Aaron M. Cohen for a confidential consultation.

The right move is to understand where your industry stands in the enforcement cycle before the government names the operation.

If you or your loved ones have been arrested or are under investigation for federal fraud charges in Florida, call Aaron M. Cohen, 24 hours a day to get help.

This article is for general informational purposes only and does not constitute legal advice. The information above describes federal fraud enforcement history and current trends as of June 2026. Outcomes in any individual case depend on facts, jurisdiction, and developments after publication. Reading this article does not create an attorney client relationship with AMC Defense Law or any of its attorneys. For advice specific to your situation, contact a licensed federal criminal defense attorney directly.